Our Work and Why It Matters
The Partnership for the Accurate Testing of Hormones (PATH) formed in 2010 to help the clinical, medical and public health communities improve patient care through more accurate and reliable hormone tests. Our vision: Better care through universal use of standardized tests.
We support research that improves the diagnosis and treatment of conditions related to having too much or too little of a certain hormone. Recently we led a landmark study that defines a "normal" range of testosterone in young adult men.
We provide technical and scientific support to the CDC’s Hormone Standardization Program. This initiative focuses on improving measurements of testosterone, vitamin D and estradiol (a female sex hormone) in patient care and research and improving the diagnosis of polycystic ovary syndrome (PCOS) and certain hormone-related cancers.
We help doctors become aware of the quality deficiencies in most of today’s tests. We educate health and medical professionals about the need for a generally accepted performance standard and the technical and policy barriers that stand in the way of better testing.
In our community and with industry, policymakers, media and the general public, we advocate for universal standards for hormone testing.
- American Association for Clinical Chemistry
- American Society for Bone and Mineral Research
- American Urological Association
- Androgen Excess and Polycystic Ovary Syndrome Society
- Association of Public Health Laboratories
- College of American Pathologists
- International Society of Andrology
- North American Menopause Society
- Pediatric Endocrine Society
- Quest Diagnostics
- National Association of Chronic Disease Directors
- American Thyroid Association
- Centers for Disease Control and Prevention
- U.S. Food and Drug Administration
- National Institues of Health - National Institute of Child Health and Human Development
- LA Biomed